Abstract
Cancer is a multifaceted disease that involves acquisition of genetic mutations, deletions, and amplifications as well as deregulation of epigenetic mechanisms that fine-tune gene regulation. Key epigenetic mechanisms that include histone modifications, DNA methylation, and non-coding RNA-mediated gene silencing are often deregulated in a variety of cancers. Subnuclear localization of key proteins in the interphase nucleus and bookmarking of genes by lineage commitment factors in mitosis-a new dimension to epigenetic control of fundamental biological processes-is also modified in cancer. In this review, we discuss the various aspects of epigenetic control that are operative in a variety of cancers and their potential for risk assessment, early detection, targeted therapy, and personalized medicine.
Original language | English (US) |
---|---|
Pages (from-to) | 2103-2108 |
Number of pages | 6 |
Journal | Journal of Cellular Physiology |
Volume | 228 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2013 |
ASJC Scopus subject areas
- Physiology
- Clinical Biochemistry
- Cell Biology